Drug intelligence / Profile preview

crystallized phenol + exosome + stem cell

Development stage: Preclinical
Modality: Small Molecules, Stem Cell Therapies → Cell Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration: Topical, Intralesional

Overview

A combination therapy approach that utilizes crystallized phenol procedure alongside stem cell and exosome applications for treating chronic wounds, particularly pilonidal sinus disease. Crystallized phenol (CP) is a minimally invasive method introduced as an improvement over liquid phenol. Stem cells and exosomes are known to promote tissue healing, reduce inflammation, and accelerate the wound healing process through their paracrine actions and intercellular communication capabilities.

Other names: MSC-derived exosomeslyophilized MSC conditioned mediummesenchymal stem cells and exosomes

Beyond the preview

Go deeper on crystallized phenol + exosome + stem cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on crystallized phenol + exosome + stem cell.

Explore the full profile